Nordion

Nordion Inc.
Company type	Subsidiary
Industry	Health Science
Founded	1946
Headquarters	Ottawa, Ontario, Canada
Area served	Global
Key people	Kevin Brooks
Products	Gamma Technologies; Medical Isotopes;
Revenue	US$244.8 million (2012); (equivalent to $324.89 million in 2023);
Number of employees	~350 (2015)
Parent	Sotera Health LLC
Website	www.nordion.com

Nordion Inc., a Sotera Health company, is a health science company that provides Cobalt-60 used for sterilization and treatment of disease (radiotherapy).

Nordion is headquartered in Ottawa, Ontario, Canada, with facilities in Vancouver, British Columbia and Laval, Quebec. Kevin Brooks is the company's CEO. It was acquired by Sotera Health in 2014 for US$805 million (equivalent to $1020.61 million in 2023).^[4]

^ "Leadership Team". Nordion. n.d. Archived from the original on 6 September 2021. Retrieved 28 December 2021.
^ "2012 Annual Report" (PDF). p. 42. Archived from the original (PDF) on 28 May 2013. Retrieved 27 December 2021.
^ "Nordion Corporate Presentation".
^ Stynes, Tess (2 June 2014). "Nordion Agrees to Sweetened Offer from Sterigenics". The Wall Street Journal. ISSN 0099-9660. OCLC 781541372. Archived from the original on 11 June 2016. Retrieved 28 December 2021.

[1] "Leadership Team". Nordion. n.d. Archived from the original on 6 September 2021. Retrieved 28 December 2021.

[nordion-2] "2012 Annual Report" (PDF). p. 42. Archived from the original (PDF) on 28 May 2013. Retrieved 27 December 2021.

[Nordion_Corporate_Presentation-3] "Nordion Corporate Presentation".

[Wall_Street_Journal-4] Stynes, Tess (2 June 2014). "Nordion Agrees to Sweetened Offer from Sterigenics". The Wall Street Journal. ISSN 0099-9660. OCLC 781541372. Archived from the original on 11 June 2016. Retrieved 28 December 2021.

[1]

[2]

[3]

[4]